English/ Chinese

Board of Directors

Founder and the First President

Xiaoyuan (Shawn) Chen (National Institutes of Health) 


Xingyu Jiang  (National Center for Nano Science and Technology of China)


Jianjun Cheng (University of Illinois at Urbana-Champaign), President-Elect

Board of Directors

Lintao Cai (Shenzhen Institutes of Advanced Technology)

Xiaoyuan Chen (National Institutes of Health) 

Jianjun Cheng (University of Illinois at Urbana-Champaign)   

Honggang Cui (Johns Hopkins University)

Weibo Cai  (University of Wisconsin - Madison)

Xiaohu GaoUniversity of Washington

Mingyuan GaoChemistry Research Institute Academia Sinica

Xingyu Jiang (National Center for Nano Science and Technology of China)  

Shaoqin Sarah Gong (University of Wisconsin–Madison)  

Can Zhang   (Center of Advanced Pharmaceuticals and Biomaterials at CPU)

Qiangbin WangChinese Academy of Sciences

Chun Li    (MD Anderson Cancer Center)   

Zhuang Liu (Soochow University)                 

Youqing Shen (Zhejiang University)            

Jun Wang (University of Science and Technology of China)   


Introduction to the board of directors:

    Dr. Xiaoyuan (Shawn) Chen received his PhD in Chemistry from the University of Idaho (1999). After two postdocs at Syracuse University and Washington University in St. Louis, he started his Assistant Professorship in 2002 and then moved to Stanford in 2004. He was promoted to Associate Professor in 2008. He moved to NIH in 2009 and became a Senior Investigator and Chief of the Laboratory of Molecular Imaging and Nanomedicine (LOMIN) at the National Institute of Biomedical Imaging and Bioengineering (NIBIB), NIH. His current research interests include development of molecular imaging toolbox for better understanding of biology, early diagnosis of disease, monitoring therapy response, and guiding drug discovery/development. His lab puts special emphasis on high-sensitivity nanosensors for biomarker detection and theranostic nanomedicine for imaging,gene and drug delivery, and monitoring of treatment. Dr. Chen has published about 500 peer-reviewed papers (H-index = 88, total citations > 28,000 based on Google Scholar) and numerous books and book chapters. He is the founding editor of journal “Theranostics” (2014 IF = 8.022). He is also the Past President of Chinese-American Society of Nuclear Medicine and Molecular Imaging (CASNMMI) and President-Elect of the Radiopharmaceutical Science Council (RPSC), Society of Nuclear Medicine and Molecular Imaging (SNMMI).

Board of Directors

Dr. Lintao Cai, Professor of CAS ”Hundred talents program”,received his Ph.D. degree in Physical Chemistry from Xiamen University (China)in 1995. From 1999 to 2001, he was sponsored by Japan Society of the Promotion of Science (JSPS) and worked as Research Fellow in Institute of Scientific and Industrial Research at Osaka University. He joined the Center for Nanoscale Science and Technology at Rice University in 2001 and Department of Electrical Engineering at the Pennsylvania State University between 2002 and 2006, and then worked as Research Scientist at Emitech, Inc. He currently works at Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences (CAS),China. Dr. Cai's scientific research areas include nanomedicine and nanobiotechnology to explore in vivo molecular imaging nanoprobes and tumor-targeted phototherapy. He has more than 106 publications in peer reviewed Journals (i.e., JACS, Nano lett, ACSNano, Adv Mater, etc) with over 3000 citations. He is a council member of Chinese Chemistry Society, a member of American Chemical Society (ACS) and Royal Society of Chmistry (RSC). 

Jianjun Cheng obtained a B.S. degree in Chemistry from Nankai University, China, in 1993, a M.S. degree in Chemistry from Southern Illinois University at Carbondale in 1996, and a Ph.D. degree in Materials Science from the University of California, Santa Barbara in 2001 with Professor Timothy Deming. He was a Senior Scientist at Insert Therapeutics, Inc. from 2001 to2004, and a Postdoctoral Research Scientist at MIT with Professor Robert Langer from 2004 to 2005. He joined the faculty of the University of Illinois at Urbana-Champaign(UIUC) as a tenure-track Assistant Professor in 2005, and was promoted to Associate Professor in 2011 and Full Professor in 2015.  Cheng is the co-inventor of 24 patents and the co-author of over 130 publications. Cheng’s research has made translational impact; he was involved in the early-stage design and development of two nanomedicine systems that are currently in clinical trials. He received a Prostate Cancer Foundation Competitive Award in 2007, a National Science Foundation CAREER Award in 2008, a Xerox Award for Outstanding Research at UIUC in 2010, a NIH Director’s New Innovator Award in 2010, the Willett Faculty Scholar Award in 2013, and the UIUC Distinguished Promotion Award in 2015 (among 5 out of 80 faculty being promoted).  He was appointed as an Associate of Center for Advanced Study, UIUC, in 2014.  He has also been on the list of Teacher Ranked As Excellent By Their Students five times at UIUC.  Cheng is currently an Associate Editor of Biomaterials Science, Royal Society of Chemistry.   He is a Fellow of the American Institute for Medical and Biological Engineering and American Chemical Society-Division of Polymer Chemistry. 

HonggangCui received a Bachelor’s degree in Polymer Materials Science and Engineering from the Beijing University of Chemical Technology in 1999, a Master’s degree in Materialogy/Chemical Engineering from Tsinghua University in 2002, and a PhD degree in Materials Science and Engineering from the University of Delaware in 2007. He was a Postdoctoral Fellow between 2007 and 2010 in the department of Materials Science and Engineering and the Institute for BioNanotechnology in Medicine at Northwestern University. He joined the Chemical and Biomolecular Engineering department at the Johns Hopkins University as Assistant Professor in 2010, and also holds joint appointments in the Department of Oncology and the Center for Nanomedicine of Wilmer Eye Institute at the Johns Hopkins University School of Medicine. He is a recipient of the NSF CAREER Award and the 3M Non-Tenured Faculty Award. His research focuses on the design, synthesis and functional assembly of peptidic molecules and therapeutic agents for applications in drug delivery, cancer diagnosis and imaging, and tumor microenvironment mimicking.

Weibo Cai is an Associate Professor (Vilas Distinguished Achievement Professor) of Radiology, Medical Physics, Biomedical Engineering, Materials Science & Engineering, and Pharmaceutical Sciences at the University of Wisconsin - Madison, USA. He received a BS degree in Chemistry from Nanjing University, China (1995) and a PhD degree in Chemistry from the University of California, San Diego (2004). Between 2005 and 2008, Dr. Cai did his post-doctoral research in the Molecular Imaging Program at Stanford University (MIPS). In February 2008, Dr. Cai joined the University of Wisconsin - Madison as a Biomedical Engineering Cluster Hire, and was promoted to Associate Professor with Tenure in 2014. Dr. Cai’s research at UW-Madison (http://mi.wisc.edu) is primarily focused on molecular imaging and nanotechnology. Dr. Cai has authored >230 peer-reviewed articles (cited >15,000 times with an H-index of >60), edited 3 books, and given >200 talks. Dr. Cai has received many awards, including the Society of Nuclear Medicine and Molecular Imaging (SNMMI) Young Professionals Committee Best Basic Science Award (2007), the European Association of Nuclear Medicine (EANM) Springer Prize (2011 & 2013), American Cancer Society Research Scholar (2013-2017), EANM Annual Congress Plenary Lecturer (2016), UW-Madison Vilas Distinguished Achievement Professor Award (2017), among many others. In addition, Dr. Cai has served on the Editorial Board of >20 scientific journals (e.g. Theranostics, JNM, EJNMMI, Molecular Pharmaceutics, etc.) and various committees such as SNMMI Committee on Awards, SNMMI House of Delegates, SNMMI Radiopharmaceutical Sciences Council (currently as the President), etc. 

Dr. Gao received his Ph.D. degree in chemistry from Indiana University, Bloomington in 2004, and his postdoctoral training from the Department of Biomedical Engineering at Georgia Tech and the Winship Cancer Institute at Emory University. He became a faculty member in the Department of Bioengineering and the Center for Nanotechnology at the University of Washington, Seattle in 2005. His research interests include cancer nanotechnology, molecular engineering, molecular imaging, and drug delivery. He has been a member of the American Chemical Society (ACS) and Biomedical Engineering Society (BMES) since 2003, and is an elected fellow of the American Institute for Medical and Biological Engineering (AIMBE). He has published 80 peer-reviewed articles, which have been cited over 15,000 times collectively (data from Google Scholar).

Prof. Dr. Mingyuan Gao received his Ph.D from Jilin University in 1995. Then, he worked as a postdoctoral researcher at MPIKG from 1996-1998, supported by Max-Planck Society and Alexander von Humboldt Fellowships, respectively. After that, he was employed as a group leader from 1999 to 2001 in the department of Physics, University of Munich. Dr. Gao took a full professor position upon a "Hundred-talent Program" from CAS in 2001. He received a National Award for Distinguished Young Scholar from NSFC in 2002. To date, with a cumulative impact factor point of 1000+, he has published 140+ peer-reviewed articles and holds 16 patents. On average, each publication has been cited 60+ times. Since 2013, Dr. Gao has been a Chair Professor and Director of Molecular Imaging and Nuclear Medicine Center at Soochow University. More details can be found at www.gaomingyuan.com.

Dr. Xingyu Jiang obtained his BS at the University of Chicago (1999) and PhD (2004) at Harvard University (with George Whitesides). He joined the NCNST in 2005 and has remained there since. His research interests include: 1) Methods for the precise control of the adhesion/migration of mammalian cells, in-vitro models of complex tissues/tissue engineering. 2) Rapid, miniaturized assays, fordisease diagnosis and environmental monitoring. A major theme is to employ microfluidics and nanotechnology to rid the reliance on bulky (often expensive)equipments typically required for these applications, for convenient point-of-care/field applications. 3) Microfluidics-based synthesis for novel pharmaceuticals and theranostic agents. 4) Automated instrumentation for chip-based assays. Prof. Jiang has more than 160 papers published in peer-reviewed journals, and more than 100 patents (several of these patents have become the core technologies for two start-up companies).Prof. Jiang is a “Hundred Talents Plan” Professor and has been awarded the National Distinguished Young Scholars granted by the NSFC.

Shaoqin Sarah Gong is a Vilas Distinguished Achievement Professor in the Department of Biomedical Engineering, Department of Materials Science and Engineering, and the Wisconsin Institute for Discovery at the University of Wisconsin–Madison. She received dual bachelor’s degrees from Tsinghua University in Materials Science and Engineering and Economics and Management in 1991. She earned a master’s degree from Tsinghua University in 1994 and a PhD degree from the University of Michigan–Ann Arbor in 1999 both in Materials Science and Engineering. Prof. Gong has co-authored more than 130 peer-reviewed journal articles. She is an editorial board member for several journals including Biomaterials, Theranostics, Biofabrication, Nanotheranostics, and the Journal of Biobased Materials and Bioenergy. She also served as an Associate Editor for Biomaterials and has received a number of awards including the NSF CAREER Award and NIH Research Development Award. Prof. Gong’s current research focuses on the development of multifunctional nanomaterials including nanomedicines and polymer nanocomposites for various applications. In the area of nanomedicines, her research group has developed a series of multifunctional drug nanocarriers including unimolecular micelles, polymer vesicles, and polymer-functionalized inorganic nanoparticles for targeted drug delivery to treat and monitor various major health threats including cancers, vascular disorders, and eye diseases. In the area of polymer nanocomposites, her research group has developed a series of high-performance functional devices (e.g., supercapacitors, nanogenerators, and sensors), flexible electronics, and functional materials (e.g., aerogels, superabsorbents, and stimuli-responsive materials). 

Qiangbin Wang obtained his B.S. and M.S. degree in Chemistry from Petroleum University of China in 1996 and 1999, and Ph.D. degree in Materials Science from East China University of China in 2002. After working as a Research Associate in Shanghai Jiaotong University for two years, he worked in Arizona State University as a Postdoctoral Research Scientist and an Assistant Research Professor from 2004 to 2008. In July of 2008, Dr. Wang joined Suzhou Institute of Nano-Tech and Nano-Bionics, Chinese Academy of Sciences, as a Principle Investigator. Professor Wang is the co-inventor of 26 patents and the co-author of over 90 publications. Due to Dr. Wang’s research in NIR-II Ag2S quantum dots and in vivo imaging, he received Distinguished Young Scholar Award from National Natural Science Foundation of China in 2014, and a Distinguished Lectureship Award from the Chemical Society of Japan in 2015.  He was appointed as the Director of Key Laboratory of Nano-Bio Interface, Chinese Academy of Sciences, and a member of Editorial Board of Nano Research journal from 2014. 

Professor Can Zhang obtained her B.S. degree in Polymer Chemistry from Nanjing University, China, in 1986. She received her M.S. degree in Pharmaceutical Chemistry from China Pharmaceutical University, China, in 2000, and completed her Ph.D. degree in Polymer Chemistry and Physics from Nanjing University, China, in 2003 with Professor Jian Shen. She joined the Center of Drug Discovery at China Pharmaceutical University (CPU) in 1986, and has served successively as assistant professor, associate professor and professor of pharmaceutical chemistry and pharmaceutics. During the period, she went to the Toyama Medical and Pharmaceutical University of as a senior visiting scholar in 2002 and the University of Maryland as a visiting professor in 2006, respectively. Now, she has served as the director of the Center of Advanced Pharmaceuticals and Biomaterials at CPU. Her current research interests are the development of new antitumor and immune regulating molecules, the innovative functional materials and targeted nanosystems for drug delivery. In the near 5 years, she has published more than 80 papers in top-tier journals, including Adv. Mater., J. Am. Chem. Soc and Angew. Chem. Int. Ed. She also signed 21 Chinese patents and 3 international patents for inventions. As the principal investigator, she has completed more than 30 of national, provincial and ministry level projects containing National Major Scientific and Technological Special Project for “Significant New Drugs Development”, National High Technology Research and Development Program of China (863 Program), National Natural Science Foundation of China, Key Project of Chinese Ministry of Education and Jiangsu province natural science foundation of China. She received a third prize for progress in science and technology of Jiangsu Province in 2002, a New Century Excellent Talents in University Award by Ministry of Education in 2006, an Excellent young backbone teacher for “blue project” Award of Jiangsu Province in 2006, a First batch of young and middle-aged scientific and technical leaders for“333 high-level talents training project” Award of Jiangsu Province in 2007, a Young scientists award nomination of Jiangsu Province in 2007, First Prize for natural science by Ministry of Education in 2009 and a Second level for“333 high-level talents training project” Award of Jiangsu Province in 2011. Besides, the graduate and undergraduate students under her guidance obtained Jiangsu excellent doctoral dissertation (3 people), Jiangsu excellent master thesis (1 people) and Jiangsu outstanding undergraduate thesis (1 people), respectively.  

Professor Chun Li earned his doctorate in chemistry at Rutgers-The State University of New Jersey. His undergraduate degree was obtained from Peking University, Beijing, China. Research in Dr. Li’s laboratory is primarily focused on two areas: 1) Develop targeted imaging probes for noninvasive characterization of molecular events associated with tumor progression and regression. Multiple imaging modalities, including PET, SPETC, MRI and optical imaging are used to acquire complementary data with increased sensitivity and selectivity for early tumor detection, tumor-marker profiling and the monitoring of early treatment responses. 2) Develop novel drug-delivery systems for selective delivery of diagnostic and therapeutic agents to the disease sites. Nanometric drug carriers are designed for selective delivery of anticancer agents to the tumor to maximize their therapeutic efficacy and minimize their toxic side effects to normal tissue. The long-term goal of Dr. Li’s laboratory is to apply the “see-and-treat” strategy in the development of targeted imaging/ therapeutic (theranostic) agents that will eventually be translated to the clinic to improve the management of cancer through early tumor detection and individualized therapy. A polymer-drug conjugate (PG-TXL) originated from his laboratory has advanced into clinical phase III trials studies. Dr. Li has more than 130 papers published in peer-reviewed journals, 28 patents (4 of which have been licensed), 1 edited book, and 14 book chapters.

Dr. Zhuang Liu is a professor at Soochow University in China. He received his BS degree from Peking University (China) in 2004 and PhD degree from Stanford University (USA) in2008. In 2009, Dr. Liu joined Institute Functional Nano & Soft Materials (FUNSOM) at Soochow University. He is now working in the field of nanomedicine to develop various functional nanomaterials for cancer theranostic. Dr. Liu has authored over 140 peer-reviewed papers, which have received a total citation of > 16,000 times and given him an H-index at 58. He was listed as one of the ‘Most Cited Chinese Researchers’ by Elsevier in 2014. He has been invited to be the Fellow of the Royal Society of Chemistry (FRSC) in 2015. The awards he received include MRS Silver Award in 2008, SCOPUS Young Researcher Award in 2012, and Young Chemist Award of Chinese Chemical Society in 2014. Now he is serving as an associated editor for Biomaterials, and as editorial board members for several journals including Nano Research and Scientific Reports. 

Youqing Shen received his B.S. and D.Sc degrees from Department of Polymer Science of Zhejiang University and PhD degree from McMaster University, Canada, in 2002.He was an assistant professor in 2003-2007 and then tenured associate professor in 2007 in the Department of Chemical Engineering of University of Wyoming,USA. In 2008 he moved to Zhejiang University as Qishi Chair professor and director of Center for Bionanoengineering. He is a recipient of Distinguished Young Scholar Fund of National Science Foundation of China (2008), and Leading Young Scientist by Ministry of Science and Technology of China, and Changjiang Scholar Chair Professor from Ministry of Education. He is the chief PI of an nanomedicine project of National Basic Research Program. His research interests are in functional polymers as bionanomaterials, nanomedicine, and drug/gene delivery. He has published 170 scientific papers with about six thousand citations with an H-index of 45. He serves as associate editors for ACS Ind Eng Chem Res and J of Nanobiotechnology.

Dr. Jun Wang is a professor of Life Sciences and Polymer Chemistry of University of Science and Technology of China, an adjunct professor of Hefei National Laboratory for Physical Sciences at the Microscale, Hefei Research Center of Physical Sciences of Chinese Academy of Sciences(CAS), and Key Laboratory of Innate Immunity and Chronic Disease of CAS. He received his B.Sc. degree in Chemistry and Cell Biology in 1993 and a Ph.D. degree in Polymer Chemistry and Physics in 1999 from Wuhan University, China.From 1999 to 2004, he worked as a postdoctoral fellow at Johns Hopkins Singapore and Johns Hopkins School of Medicine. In 2004, he joined the faculty of University of Science and Technology of China as a full professor. His main research interests cover novel drug delivery systems and nanomedicine. He published 130 peer-reviewed papers with total over 4000 citations. He has been served as an Editorial Board Member of Biomaterials Science (2012~), ActaBiomaterialia (2014~) and ChemNanoMat (2014~), a member of Chinese Society for Biomaterials. In 2013, he received the First prize of Natural Science Award of the Ministry of Education of China. He was selected as the awardee of “One Hundred Talents” of Chinese Academy of Science in 2005 and “National high-level personnel of special support program” in 2013. He received “Outstanding Young Scholar Award” of National Science Foundation of China in 2011.

Dr. Zhen Gu is currently a Full Professor in the Department of Bioengineering at University of California, Los Angeles (UCLA). He received B.S. degree in Chemistry and M.S. degree in Polymer Chemistry and Physics from Nanjing University. In 2010, he obtained Ph.D. in the Department of Chemical and Biomolecular Engineering at UCLA. He was a postdoctoral associate working with Dr. Robert Langer at MIT and Harvard Medical School during 2010 to 2012. Before he moved to UCLA in 2018, he had been appointed as Jackson Family Distinguished Professor in the Joint Department of Biomedical Enginering at University of North Carolina at Chapel Hill and North Carolina State University. Dr. Gu’s group studies controlled drug delivery, bio-inspired materials and nanobiotechnology.  He has published over 140 research papers and applied over 50 patents. He has co-founded 3 start-up companies. He is the recipient of the Sloan Research Fellowship (2016), Young Investigator Award of the Controlled Release Society (CRS) (2017), Biomaterials Science Lectureship Award (2018), Pathway Award of the American Diabetes Association (ADA) (2015) and Young Innovator Award in Cellular and Molecular Engineering of the Biomedical Engineering Society (BMES) (2015). MIT Technology Review listed him as one of the global top innovators under the age of 35 (TR35). He serves as an Associate Editor for Nano Research.

Dr. Liangfang Zhang received his B.E. and M.S. degrees in Chemical Engineering from Tsinghua University, and his Ph.D. in Chemical & Biomolecular Engineering from the University of Illinois at Urbana-Champaign in 2006 under the supervision of Prof. Steve Granick. He was a postdoctoral associate in the laboratory of Prof. Robert Langer at MIT during 2006-2008.  He joined the Department of Nanoengineering at UC San Diego as an Assistant Professor in July 2008 and was promoted to an Associate Professor with tenure in March 2012 and to Professor in July 2014. Dr. Zhang’s research interests focus on biomimetic nanomedicine, with a particular interest in creating and evaluating nanostructured biomaterials for drug delivery, detoxification and vaccination for treatment of infectious diseases and cancer. He has published 175 peer-reviewed articles and holds 55 issued/pending patents. He received the ACS Victor K. LaMer Award (2009), UCSD Jacobs School of Engineering Best Teacher Award (2011), ACS Unilever Award (2012), MIT Technology Review’s TR35 Innovator Award (2013), AIChE Allan P. Colburn Award (2014), AIMBE Fellow (2015), Popular Science’s Brilliant 10 Award (2016), U.S. Department of State ASPIRE Award (2017), and Kabiller Young Investigator Award (2017).